Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

NCT07202494 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT07202494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07202494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2025
Completion date
May 18, 2030
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, amyotrophic lateral sclerosis (als), epilepsy, healthy aging, mild traumatic brain injury, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), neuromyelitis optica spectrum disorders, parkinson disease, temporal lobe epilepsy